Trademark: 90864504
Word
YOU DESERVE BRAVE SCIENCE
Status Date
Tuesday, January 23, 2024
Filing Date
Wednesday, August 4, 2021
Published for Opposition
Tuesday, June 7, 2022
5 Pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; pharmaceutical preparations for the treatment of tardive dyskinesia; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy, namely, Friedreich's ataxia and congenital birth defects; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions, namely, rare pediatric epilepsies, SCN8A developmental and epileptic encephalopathy, and congenital adrenal hyperplasia
Jan 25, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 23, 2024
Sou Extension 3 Granted
Jan 23, 2024
Sou Extension 3 Filed
Jan 23, 2024
Sou Teas Extension Received
Jul 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2023
Sou Extension 2 Granted
Jul 24, 2023
Sou Extension 2 Filed
Jul 24, 2023
Sou Teas Extension Received
May 25, 2023
Corrected Noa E-Mailed
May 20, 2023
Notice Of Approval Of Extension Request E-Mailed
May 19, 2023
Sou Extension 1 Granted
Feb 1, 2023
Sou Extension 1 Filed
May 19, 2023
Divisional Processing Complete
Feb 1, 2023
Divisional Request Received
Apr 25, 2023
Case Assigned To Intent To Use Paralegal
Mar 6, 2023
Case Assigned To Intent To Use Paralegal
Feb 1, 2023
Teas Request To Divide Received
Feb 1, 2023
Sou Teas Extension Received
Aug 2, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 7, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 7, 2022
Published For Opposition
May 18, 2022
Notification Of Notice Of Publication E-Mailed
May 4, 2022
Approved For Pub - Principal Register
May 3, 2022
Assigned To Examiner
Sep 29, 2021
New Application Office Supplied Data Entered
Aug 7, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
